• By Laura Panos Smith
  • Posted October 4, 2017

Hereditary Cancer Tests: Is Bigger Always Better?

Just five short years ago, hereditary cancer testing was much simpler for patients and healthcare providers.  There were finite criteria, associated with a handful of genetic conditions, and healthcare providers could order single-gene (or single-syndrome) genetic testing for patients who met those criteria.  Since 2012, the field of genetics …

  • By James L. Wilder, MD
  • Posted September 11, 2017

The Benefits of Genetic Testing for Your GYN/ONC Practice

An estimated 22,440 women will be diagnosed with ovarian cancer in 2017. Early detection is critical for successful treatment of this disease, which has a 5-year survival rate of 92.5% for women who are diagnosed with early stage/localized ovarian cancer.1 We hope that Ovarian Cancer Awareness Month will bring more women to their healthcare providers …

  • By Brian Helfand, MD, PhD
  • Posted September 7, 2017

How Genetic Testing Can Benefit Your Urology Practice

An estimated 161,360 men will be diagnosed with prostate cancer in 2017; early detection is critical for successful treatment of this disease.  We hope that Prostate Cancer Awareness Month will bring more men to their healthcare providers asking about prostate cancer screening or about their risk of developing this disease. Genetic testing for …

  • By Taylor Leigh
  • Posted August 29, 2017

Ambry's Agenda for an Influential NSGC 2017

August is quickly wrapping up and all of us at Ambry are preparing for the 36th Annual National Society of Genetic Counselors (NSGC) Conference. We are excited to present new research, participate in panels, and display posters – all focused on the importance of evidence-based, quality genetic testing. The Annual NSGC Conference serves as a …

  • By Taylor Leigh
  • Posted August 15, 2017

Ambry Advances Understanding of Human Disease Through Epilepsy Gene Research

  At Ambry, we believe working together is better, that sharing data is essential to finding answers faster. Our scientists embody these beliefs by collaborating with other talented researchers and physicians to understand human disease, most recently in epilepsy genetics. We are proud to have contributed to the clinical research reviewed …

  • By Taylor Leigh
  • Posted July 27, 2017

Ambry GC Melissa Truelson Advances Qualified Genetic Counseling in Minnesota

  *Editor’s Note: For this article, we interviewed one of Ambry’s genetic counselors, Melissa Truelson, MS, CGC, who was instrumental in passing local healthcare legislation in her home state of Minnesota. One of Ambry’s genetic counselors, Melissa Truelson, MS, CGC, continually strives to advance qualified genetic counseling …

  • By Jessica Profato
  • Posted July 26, 2017

Why Paired Tumor/Germline Testing?

Germline genetic testing is used by many labs to evaluate a patient’s predisposition to hereditary cancer, and produces excellent results in its analysis of many genetic conditions. However, when germline testing is combined with tumor testing as a single paired test, it may yield even more helpful results in certain situations. Specifically, …

  • By Melissa Parra, MS, CGC
  • Posted June 30, 2017

How to Build a Smarter Panel

At Ambry, we offer many different options for genetic testing, sometimes more than one for the same disease, which we call “panels”. Ambry’s multi-gene testing panels are comprised of genes that have a threshold of evidence between a gene and the disorder for which a patient is being tested.  These panels are made up of genes that are known …

  • By Pearl Yee, M.D.
  • Posted June 27, 2017

Physician Spotlight: Integrating Genetic Testing for Hereditary Cancer Into Your OBGYN Practice

Genetic testing for hereditary cancer has evolved significantly over the past several years. We are continually learning more information about genes that are associated with increased risks for various cancers; and there are many different genetic tests available that can help you learn more precise information about your patients’ cancer risks, …

  • By Deepti Babu, MS, CGC
  • Posted June 7, 2017

Improve Patient Care by Reducing Ambiguity in Gene-Disease Relationships

New discoveries are rapidly expanding our understanding of the human genome, and diagnostic laboratories use different approaches to interpret this knowledge. A challenge for laboratories is translating vast amounts of published evidence to determine the clinical validity of gene-disease relationships, which need to be integrated into a patient’s …